At the time of writing, Resmed Inc [RMD] stock is trading at $219.72, down -0.23%. An important factor to consider is whether the stock is rising or falling in short-term value. The RMD shares have lost -2.36% over the last week, with a monthly amount drifted -7.46%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Piper Sandler started tracking the stock with Neutral rating on January 10, 2025, and set its price target to $252. On December 13, 2024, Stifel initiated with a Hold rating and assigned a price target of $250 on the stock. Robert W. Baird started tracking the stock assigning a Outperform rating and suggested a price target of $280 on September 24, 2024. Wolfe Research downgraded its rating to a Underperform but $180 remained the price target by the analyst firm on September 18, 2024. Needham downgraded its rating to Hold for this stock on September 04, 2024. In a note dated June 25, 2024, Oppenheimer downgraded an Perform rating on this stock.
For the past year, the stock price of Resmed Inc fluctuated between $172.19 and $263.05. Currently, Wall Street analysts expect the stock to reach $236.8 within the next 12 months. Resmed Inc [NYSE: RMD] shares were valued at $219.72 at the most recent close of the market. An investor can expect a potential return of 7.77% based on the average RMD price forecast.
Analyzing the RMD fundamentals
According to Resmed Inc [NYSE:RMD], the company’s sales were 4.93B for trailing twelve months, which represents an 10.26% jump. Gross Profit Margin for this corporation currently stands at 0.58% with Operating Profit Margin at 0.32%, Pretax Profit Margin comes in at 0.31%, and Net Profit Margin reading is 0.25%. To continue investigating profitability, this company’s Return on Assets is posted at 0.17, Equity is 0.25 and Total Capital is 0.25. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 217.22 points at the first support level, and at 214.72 for the second support level. However, for the 1st resistance point, the stock is sitting at 222.52, and for the 2nd resistance point, it is at 225.32.
Ratios To Look Out For
It is important to note that Resmed Inc [NYSE:RMD] has a current ratio of 3.33. On the other hand, the Quick Ratio is 2.29, and the Cash Ratio is 0.61. Considering the valuation of this stock, the price to sales ratio is 6.55, the price to book ratio is 6.14 and price to earnings (TTM) ratio is 25.96.
Transactions by insiders
Recent insider trading involved Sandercock Brett, Chief Financial Officer, that happened on Mar 10 ’25 when 1000.0 shares were sold. Chief Commercial Officer, SaaS, Ghoshal Kaushik completed a deal on Mar 10 ’25 to sell 9745.0 shares. Meanwhile, Chief Executive Officer Farrell Michael J. sold 8009.0 shares on Mar 07 ’25.
